Skip to main content
Clinical Trials/NCT03411317
NCT03411317
Active, Not Recruiting
N/A

Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling (AS-PROGRESSION)

University Hospital, Rouen1 site in 1 country350 target enrollmentDecember 11, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Aortic Valve Stenosis
Sponsor
University Hospital, Rouen
Enrollment
350
Locations
1
Primary Endpoint
Composite primary endpoint: haemodynamic and anatomical progression of Aortic Stenosis
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

Aortic stenosis (AS) is the most frequent valvulopathy in Western countries. The prevalence of AS is constantly increasing due to the aging of the population. Although significant progress has been made in understanding the pathophysiological mechanisms underlying the onset and progression of AS, there is no medical treatment to slow or prevent its progression. The only treatment available is Aortic Valve Replacement (AVR) performed by surgery or by catheterization (TAVI).

AS is associated with an increase of post-load which leads the left ventricular myocardium to hypertrophy. Associated with hypertrophy, myocardial fibrosis will gradually develop. Despite interesting data, many unknowns persist and remain to be identified.

The aim of the study is to evaluate prospectively the progression and impact of AS in 500 patients using clinical, biological, echocardiographic and MRI parameters performed annually.

Registry
clinicaltrials.gov
Start Date
December 11, 2017
End Date
December 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Rouen
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aortic stenosis (peak aortic valve velocity (Vmax) ≥2.5m/s )

Exclusion Criteria

  • rheumatismal or congenital aortic stenosis
  • aortic insufficiency (grade \>= 2/4)
  • Associated valvulopathy (grade \>= 2/4)
  • Angina, syncope, dyspnea NYHA 3-4
  • Heart failure antecedent
  • Myocardial infarction antecedent
  • Severe renal failure
  • indication of Aortic Valve Replacement (Surgery or TAVI)
  • Cardiac surgery (Aorta abdominal) antecedent
  • Complex congenital cardiopathy

Outcomes

Primary Outcomes

Composite primary endpoint: haemodynamic and anatomical progression of Aortic Stenosis

Time Frame: Year 4

CT scan and MRI

Secondary Outcomes

  • Determinants of left ventricular remodeling(Year 4)
  • Progression of left ventricular remodeling(Year 4)
  • Prognostic value of ventricular mass, type of ventricular remodeling and fibrosis in Aortic Stenosis(Year 4)

Study Sites (1)

Loading locations...

Similar Trials